ArticleBMC cancer2016

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.

Yaewon Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.